Hyundai Bioland
현대바이오랜드 · 052260
Materials Chemicals · KOSDAQ
Market cap US$82M (₩113.1B)
Overview
Hyundai Bioland makes ingredients derived from natural sources, such as hyaluronic acid, beta-glucan, and plant-based collagen, used in cosmetics, health supplements, pharmaceutical actives, and medical devices including dental bone-regeneration materials.
It supplies these ingredients to cosmetics companies, pharmaceutical firms, and healthcare brands globally, and also distributes premium international health supplement brands exclusively within South Korea. Listed on KOSDAQ, Korea's tech and small-cap board, its cosmetics ingredient business accounts for the largest share of revenue, with brand distribution and medical devices making up most of the remainder.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$73.7M
- FY2024US$86.6M
- FY2025US$94.6M
Operating profit
- FY2023US$5.1M
- FY2024US$11.9M
- FY2025US$9.2M
Net income
- FY2023US$5.8M
- FY2024US$4.1M
- FY2025US$183.1K
Key ratios (FY2025)
Why it matters
The company exclusively distributes Nestlé Health Science brands, including Solgar and Vital Proteins, in South Korea, operating dedicated retail shops under that partnership.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?